Atomic-resolution structure of a disease-relevant Aβ(1–42) amyloid fibril

Marielle Aulikki Wälti(Brookhaven National Laboratory), Francesco Ravotti(ETH Zurich), Hiromi Arai(University of California, Irvine), Charles Glabe(King Abdulaziz University), Joseph S. Wall(Brookhaven National Laboratory), Anja Böckmann(Université Claude Bernard Lyon 1), Peter Güntert(Goethe University Frankfurt), Beat H. Meier(ETH Zurich), Roland Riek(ETH Zurich)
Proceedings of the National Academy of Sciences
July 28, 2016
Cited by 822Open Access
Full Text

Abstract

Amyloid-β (Aβ) is present in humans as a 39- to 42-amino acid residue metabolic product of the amyloid precursor protein. Although the two predominant forms, Aβ(1-40) and Aβ(1-42), differ in only two residues, they display different biophysical, biological, and clinical behavior. Aβ(1-42) is the more neurotoxic species, aggregates much faster, and dominates in senile plaque of Alzheimer's disease (AD) patients. Although small Aβ oligomers are believed to be the neurotoxic species, Aβ amyloid fibrils are, because of their presence in plaques, a pathological hallmark of AD and appear to play an important role in disease progression through cell-to-cell transmissibility. Here, we solved the 3D structure of a disease-relevant Aβ(1-42) fibril polymorph, combining data from solid-state NMR spectroscopy and mass-per-length measurements from EM. The 3D structure is composed of two molecules per fibril layer, with residues 15-42 forming a double-horseshoe-like cross-β-sheet entity with maximally buried hydrophobic side chains. Residues 1-14 are partially ordered and in a β-strand conformation, but do not display unambiguous distance restraints to the remainder of the core structure.


Related Papers

No related papers found

Powered by citation graph analysis